|
January 2009: A COMMENT published in The Lancet, summarizing Inverseon's first clinical trial of INV102 for asthma.
February 2009: "β-Adrenoceptor signaling is required for the development of an asthma phenotype in a murine model" published in the Proceedings of the National Academy of Sciences (PNAS)
EDITORIAL in the same issue of PNAS commented on the publication.
|
